Protective Effect of Anar-5 Herbal Treatment on Experimental Chronic Atrophic Gastritis in Wistar Rats
Chronic gastritis is a long progressive illness caused by inflammation of the gastric mucosa; combined with loss of epithelial regeneration, atrophy of lymphoid tissue and impairment of gastric secretory and motility functions.1 Evidence of illness is noted by inflammation and redness to the mucosa followed by stomach ulcer through reactivation and recrudescence and it is caused by loss of balance between musical protective and damaging factors. The loss of acid base balance and mucosal bicarbonate deficiency in the stomach constitute the major role in pathogenesis of inflammation and ulcers. The mucus of gastric mucosal layer softens the epithelium while it protects mucous membranes from hydrochloric acid. Glycoprotein included in the mucin is not able to protect mucous membranes by itself and it becomes protective after transforming into the gel in alkaline environment. Digestive tract diseases are the second leading cause out of top 5 morbidity causes in Mongolia.2 Chronic gastritis accounts for 12% of total incidences of digestive tract diseases.3 There was an increased demand to study the effects of pharmacologic treatment with low cost and less adverse effect during this period of high morbidity of digestive tract among the population and it became the main reason to conduct this study. The Anar-5 herbal medicine has been used for early symptoms of any stomach pain, vomiting, disorders of digestion, stomach irritation and loss of appetite in Mongolian traditional medicine. In order to provide scientifically based description for effect/mechanisms of this medicine, we have tried to identify protective effects of Anar-5 herbal medicine for stomach as we create the model of the chronic gastritis.
2. Ganchimeg U, Angarmurun D, Davaalham D. The current situation of the non-communicable disease in Mongolia. Mongolian journal of health sciences 2010; 1:7 .
3. Tumurbaatar N: Hot-Natured Disorders in Traditional Mongolian Medicine. 1998, Eruul enkh press, Ulaanbaatar
4. Manag rinchin junai: Traditional Medical source book. 1978, People's Republic of China: “Inner Mongolian medical treasurers” printing house, Ulaanbaatar
5. Ligaa U, Davaasuren B, Ninjil N: Mongolian Medicinal Plants Using in Western and Eastern Medicine. 2005, JKC printing, Ulaanbaatar
6. Myagmar BE, Aniya Y: Free radical scavenging action of medicinal herbs from Mongolia. Phytomedicine. 2000, 7: 221-9. 10.1016/S0944-7113(00)80007-0.
7. Takao Noguchi, Eiji Umegaki, Chikao Shimamoto, Ken-Ichi Katsu. Effect of Long-term Administration of Ammonia Water on Rat Gastric Mucosa-Combined Effect of Gastric Mucosal Protective Agents. Bulletin of the Osaka Medical College. 2007; 69-78.
8. Tsuji S, Tsujii M, Murata H, Nishida T, Komori M, Yasumaru M, Ishii S, Sasayama Y, Kawano S, Hayashi N. Helicobacter pylori eradication to prevent gastric cancer: Underlying molecular and cellular mechanisms. World J Gastroenterol. 2006; 12(11): 1671-1680.
9. Brzozowski T, Konturek PC, Konturek SJ. Mucosal irritation, adaptive cytoprotection, and adaptation to topical ammonia in the rat stomach. Scand. J. Gastroenterol. 1996; 31(9): 837-846.
10. Xiang Z, Si JM, Huang HD. Chronic gastritis rat model and role of inducing factors. World J Gastroenterol 2004; 10(21): 3212-3214.
11. Wang LJ, Chen SJ, Chen Z, Cai JT, Si JM. Morphological and pathologic changes of experimental chronic atrophic gastritis (CAG) and the regulating mechanism of protein expression in rats. Journal of Zhejiang University SCIENCE B. 2006; 7(8):634-640.
12. Si J, Zhou W, Wu J, Cao Q, Xiang Z, Jiang L, Lü W, Huang H. Establishment of animal model of chronic atrophic gastritis and a study on the factors inducing atrophy. Chinese Medical Journal 2001; 114(12): 1323-1325.
13. Zhao W, Zhu F, Shen W, Fu A, Zheng L, Yan Z, Zhao L, Fu G. Protective effects of DIDS against ethanol-induced gastric mucosal injury in rats. Acta Biochim Biophys Sin (2009): 301–308.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
4. In case of virtual slide publication the authors agree to copy the article in a structural modified version to the journal's VS archive.